PLRX Activist 13D/13G Filings - PLIANT THERAPEUTICS INC.

Real time Form 13D and 13G transaction reports:

Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Goto Prev, 0, 1

Reported DateTime	Type	Company Symbol	Filed By Symbol	Shares Owned % Owned	Shares Vs. Prev Report	Filing
2022-02-11 1:51 pm Purchase	13G	PLIANT THERAPEUTICS INC PLRX	CHI Advisors LLC	2,569,479 7.13%	214,680 (+9.12%)	View
2022-02-09 10:24 am Purchase	13G	PLIANT THERAPEUTICS INC PLRX	FMR LLC	5,405,849 14.999%	83,693 (+1.57%)	View
2021-03-02 3:41 pm Purchase	13G	PLIANT THERAPEUTICS INC PLRX	CHI Advisors LLC	2,354,799 6.6%	2,354,799 (New Position)	View
2021-02-16 4:17 pm Purchase	13G	PLIANT THERAPEUTICS INC PLRX	Third Rock Ventures III L.P.	5,839,160 16.5%	5,839,160 (New Position)	View
2021-02-16 4:08 pm Sale	13G	PLIANT THERAPEUTICS INC PLRX	Redmile Group LLC	3,388,376 9.6%	-22,281 (-0.65%)	View
2021-02-12 4:11 pm Purchase	13G	PLIANT THERAPEUTICS INC PLRX	EVENTIDE ASSET MANAGEMENT LLC	2,838,125 8%	2,838,125 (New Position)	View
2021-02-08 10:29 am Sale	13G	PLIANT THERAPEUTICS INC PLRX	FMR LLC	5,322,156 15%	-10,545 (-0.20%)	View
2020-07-10 11:38 am Purchase	13G	PLIANT THERAPEUTICS INC PLRX	FMR LLC	5,332,701 14.999%	5,332,701 (New Position)	View
2020-06-15 4:40 pm Purchase	13G	PLIANT THERAPEUTICS INC PLRX	Novartis Institutes for BioMedical Research Inc.	2,153,526 6.1%	2,153,526 (New Position)	View
2020-06-09 4:18 pm Purchase	13G	PLIANT THERAPEUTICS INC PLRX	Redmile Group LLC	3,410,657 9.6%	3,410,657 (New Position)	View

Goto Prev, 0, 1